BeStock  
Stocks › Biotechnology › XENE

Xenon Pharmaceuticals XENE

US equityMarket cap rank #2343Biotechnology
$37.57 −$0.45 (-1.18%)
Market closed · Oct 6, 12:20 am ET · Last extended-hours $37.72 +0.40%
Open$38.02
Prev close$38.02
Day range$37.00 – $38.23
Volume1.70M
Market cap$3.64B
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, not just today’s reading.

Technical signals

Trend readStrong downtrend

1 bullish · 5 bearish of 7 signals

IndicatorValueSignalReading
Price vs 20-day average-18.3%BearishTrading below the 20-day average of $45.98
Price vs 50-day average-32.8%BearishTrading below the 50-day average of $55.87
Price vs 200-day average-29.2%BearishTrading below the 200-day average of $53.07
50-day vs 200-day50d above 200dBullishThe 50-day average is above the 200-day average
RSI (14)23.7NeutralOversold territory (30 or below); selling this heavy often eases
MACD (12,26,9)-6.04BearishMACD line is below its signal line
Bollinger band position29%BearishInside the 20-day bands

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

Levels & volatility

Moving averages

AverageLevelPrice vs. it
20-day SMA$45.98-18.3%
50-day SMA$55.87-32.8%
200-day SMA$53.07-29.2%

Recent price levels

LevelPrice
20-day high$60.36
20-day low$36.07
60-day high$69.58
60-day low$36.07
Upper Bollinger band$66.35
Lower Bollinger band$25.62

The 50-day average is currently 5.3% above the 200-day average — consistent with a “golden cross” (bullish) configuration.

30-day volatility111.7%
Average true range7.77% of price
Max drawdown (1y)-48.5%
Volume (10d vs 90d)1.70x

Discussion

No comments yet — be the first to weigh in on XENE.

Leave a comment

Scroll to Top